$AQST
Aquestive Therapeutics, Inc. Common Stock
XNAS•Health Care•Pharmaceutical Preparations
Aquestive Therapeutics, Inc. Common Stock
XNAS•Health Care•Pharmaceutical Preparations
Why is AQST down today? It is at $3.69 (-2.51%), and our scanner flagged it 147 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment AQST spikes, and full due diligence on AQST — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $AQST 147 times in the last 30 days. Create a free account to track $AQST, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Here is the latest on AQST from our scanner (live price and day move above). Our scanner has fired 11 unusual-volume and momentum alerts on AQST today, peaking at 10.0x its normal volume. A recent catalyst in the news: “Aquestive Therapeutics to Present at the Piper Sandler 38th Annual Healthcare Conference.”
Likely catalystJefferies Global Healthcare Conference November 16, 2026, from an SEC filing. Read it →Latest filing4Insider trade (Form 4)Nov 16, 2026 · 2 days agoAcross every filing on file, supply equal to at least 0.65% of the tradeable float is in play - 0.65% more can still be issued.
Some filings did not state a size, so these are floors.
At-the-market (ATM) offering active — the company can keep selling new shares into the market over time (ongoing)
230,271 new shares · At-the-market (ATM) program — sells new shares into the market gradually over time
Sources: float & market cap via Polygon · short interest via FINRA · borrow & shortability via Alpaca · SSR from Reg SHO 201 · filings & dilution via SEC EDGAR · analysts via Nasdaq.
Auto-generated from public data for research and education. Not investment advice.
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Davis Matthew W. Officer | Sold (automatic/other) | -7K | sold 7.6% | 88K | $26K at $3.55 | Nov 12, 26 |
Davis Matthew W. Officer | Sold (automatic/other) | -5K | sold 5.3% | 95K | $19K at $3.52 | Nov 10, 26 |
Daly Richard J Director | Bought (open market) | +28K 0.02% of company | n/a | 28K | $99K at $3.53 | Nov 10, 26 |
Cochran John Director | Acquired (grant/award) | +62K 0.05% of company | added 63% | 162K | n/a | Oct 21, 26 |
Barber Daniel Officer | Sold (automatic/other) | -25K 0.02% of company | sold 3.8% | 627K | $106K at $4.22 | Oct 15, 26 |
Barber Daniel Officer | Sold (automatic/other) | -25K 0.02% of company | sold 3.7% | 652K | $121K at $4.82 | Sep 15, 26 |
Boyd Peter E. Officer | Other | 2K | added 0.8% | 284K | $2K at $0.960 | Sep 9, 26 |
Korczynski Sherry Officer | Sold (automatic/other) | -9K | sold 3.6% | 236K | $46K at $5.22 | Sep 9, 26 |
Korczynski Sherry Officer | Other | 9K | added 3.7% | 244K | $23K at $2.65 | Sep 9, 26 |
Barber Daniel Officer | Other | 92K 0.07% of company | added 16% | 677K | $88K at $0.960 | Sep 8, 26 |
Jung Cassie Officer | Other | 5K | added 2.3% | 207K | $4K at $0.960 | Sep 3, 26 |
Barber Daniel Officer | Sold (automatic/other) | -25K 0.02% of company | sold 4.1% | 586K | $107K at $4.29 | Aug 17, 26 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
The tickers our scanner is lighting up most over the last 48 hours.
Comparable names in pharmaceutical preparations, closest in size first.
Here is the latest on AQST from our scanner (live price and day move above). Our scanner has fired 11 unusual-volume and momentum alerts on AQST today, peaking at 10.0x its normal volume. A recent catalyst in the news: “Aquestive Therapeutics to Present at the Piper Sandler 38th Annual Healthcare Conference.”
AQST last traded at $3.69, down 2.51% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
The AQST Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged AQST 147 times in the last 30 days.
AQST (Aquestive Therapeutics, Inc. Common Stock) trades on XNAS, with a market cap of about $475M in the Pharmaceutical Preparations sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge AQST for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$AQST discussion
Sign in to ask a question or join the discussion.